Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas ; volume:13 ; number:1 ; day:19 ; month:12 ; year:2013 ; pages:1-9 ; date:12.2013
BMC cancer ; 13, Heft 1 (19.12.2013), 1-9, 12.2013
- Creator
-
Voorham, Quirinus JM
- Contributor
-
Janssen, Jerry
Tijssen, Marianne
Snellenberg, Suzanne
Mongera, Sandra
van Grieken, Nicole CT
Grabsch, Heike
Kliment, Martin
Rembacken, Bjorn J.
Mulder, Chris JJ
van Engeland, Manon
Meijer, Gerrit A.
Steenbergen, Renske DM
Carvalho, Beatriz
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-13-603
- URN
-
urn:nbn:de:1111-201603046360
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Voorham, Quirinus JM
- Janssen, Jerry
- Tijssen, Marianne
- Snellenberg, Suzanne
- Mongera, Sandra
- van Grieken, Nicole CT
- Grabsch, Heike
- Kliment, Martin
- Rembacken, Bjorn J.
- Mulder, Chris JJ
- van Engeland, Manon
- Meijer, Gerrit A.
- Steenbergen, Renske DM
- Carvalho, Beatriz
- SpringerLink (Online service)
Other Objects (12)
Promoter methylation, transcription, and retrotransposition of LINE-1 in colorectal adenomas and adenocarcinomas
The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis
Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas
Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival
Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists
Dysregulation of Wnt-β-catenin [Wnt-beta-catenin] pathway in pituitary adenomas and its stimulation by CRH and inhibition by SRIF in ACTH-secreting pituitary adenomas
Gene Promoter Methylation in Endometrial Carcinogenesis
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
MLH1–93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF V600E mutation
Genome-wide DNA methylation profiles distinguish silent from non-silent ACTH adenomas
Promoter methylation, transcription, and retrotransposition of LINE-1 in colorectal adenomas and adenocarcinomas
The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis
Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas
Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival
Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists
Dysregulation of Wnt-β-catenin [Wnt-beta-catenin] pathway in pituitary adenomas and its stimulation by CRH and inhibition by SRIF in ACTH-secreting pituitary adenomas
Gene Promoter Methylation in Endometrial Carcinogenesis
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
MLH1–93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF V600E mutation
Genome-wide DNA methylation profiles distinguish silent from non-silent ACTH adenomas
Promoter methylation, transcription, and retrotransposition of LINE-1 in colorectal adenomas and adenocarcinomas
The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis
Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas
Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival
Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists
Dysregulation of Wnt-β-catenin [Wnt-beta-catenin] pathway in pituitary adenomas and its stimulation by CRH and inhibition by SRIF in ACTH-secreting pituitary adenomas
Gene Promoter Methylation in Endometrial Carcinogenesis
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
MLH1–93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF V600E mutation